Meloche S, McNicoll N, Liu B, Ong H, De Léan A
Laboratory of Molecular Pharmacology, Clinical Research Institute of Montreal, Canada.
Biochemistry. 1988 Oct 18;27(21):8151-8. doi: 10.1021/bi00421a025.
The atrial natriuretic factor (ANF) R1 receptor from bovine adrenal zona glomerulosa was solubilized with Triton X-100 and purified 13,000-fold, to apparent homogeneity, by sequential affinity chromatography on ANF-agarose and steric exclusion high-performance liquid chromatography. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and silver staining of the purified receptor preparation in the absence or presence of dithiothreitol revealed a single protein band of Mr 130,000. Affinity cross-linking of 125I-ANF to the purified receptor resulted in the labeling of the Mr 130,000 band. The purified receptor bound ANF with a specific activity of 6.8 nmol/mg of protein, corresponding to a stoichiometry of 0.9 mol of ANF bound/mol of Mr 130,000 polypeptide. Starting with 500 g of adrenal zona glomerulosa tissue, we obtained more than 500 pmol of purified receptor with an overall yield of 9%. The purified receptor showed a typical ANF-R1 pharmacological specificity similar to that of the membrane-bound receptor. The homogeneous Mr 130,000 receptor protein displayed high guanylate cyclase activity [1.4 mumol of cyclic GMP formed min-1 (mg of protein)-1] which was not stimulated by ANF. This finding supports the notion that the ANF binding and the guanylate cyclase activities are intrinsic components of the same polypeptide. Finally, the purified ANF-R1 receptor retained its sensitivity to modulation by amiloride, suggesting the presence of an allosteric binding site for amiloride on the receptor protein.
用Triton X-100使牛肾上腺球状带的心房利钠因子(ANF)R1受体溶解,并通过在ANF-琼脂糖上的连续亲和层析和空间排阻高效液相色谱法将其纯化13000倍,达到表观均一性。在有无二硫苏糖醇的情况下,对纯化的受体制剂进行十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和银染,结果显示一条Mr为130000的单一蛋白带。125I-ANF与纯化受体的亲和交联导致Mr为130000的条带被标记。纯化的受体结合ANF的比活性为6.8 nmol/mg蛋白,对应于每摩尔Mr为130000的多肽结合0.9摩尔ANF的化学计量比。从500 g肾上腺球状带组织开始,我们获得了超过500 pmol的纯化受体,总产率为9%。纯化的受体显示出与膜结合受体相似的典型ANF-R1药理特异性。均一的Mr为130000的受体蛋白表现出高鸟苷酸环化酶活性[1.4 μmol环磷酸鸟苷形成·min-1·(mg蛋白)-1],该活性不受ANF刺激。这一发现支持了ANF结合和鸟苷酸环化酶活性是同一多肽的内在组成部分这一观点。最后,纯化的ANF-R1受体保留了其对阿米洛利调节的敏感性,表明受体蛋白上存在阿米洛利的变构结合位点。